Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid. They are also the first to demonstrate that patients with dry eye disease experienced reduced signs and symptoms of the condition in response to a new eye drop treatment - made from pooled human antibodies - that targets ACPAs.

A team led by a scientist at Scripps Research has invented a new genomics technique for tracking down the causes of rare genetic diseases. The technique, which the researchers report in Science, makes use of the fact that people inherit two copies or "alleles" of virtually every gene, one from the mother and one from the father.

An artificial intelligence/machine learning model to predict which scientific advances are likely to eventually translate to the clinic has been developed by Ian Hutchins and colleagues in the Office of Portfolio Analysis (OPA), a team led by George Santangelo at the National Institutes of Health (NIH). This work, described in a Meta-Research article published October 10 in the open-access journal PLOS Biology,

With inhaler in hand, Dr. Cheng Yuet went over every detail to make sure the patient understood how the drug would control their COPD symptoms. Dr. Yuet is proving what a difference it makes when pharmacists are integrated into the health care team. As part of an innovative model being used at UNT Health Science Center, Dr. Yuet and three other pharmacists manage the care of patients with chronic diseases such as asthma, diabetes and hypertension.

Patients with cancer should receive a tailored exercise prescription to protect their heart, reports a paper published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).

Cardiovascular diseases are common side effects in patients with cancer.

In the West, the number of people challenging scientific authority has been growing in past decades. This has, among other things, led to a decline in the support for mass vaccination programmes and to an increase in alternative forms of treatment. In China, however, activists are defending modern medical science and criticising Traditional Chinese Medicine, which hospitals are obliged to offer to patients on an equal footing with modern medical care.

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.